Related Experiment Videos
Milrinone, a bridge to heart transplantation
D M Watson1, K M Sherry, G A Weston
1Northern General Hospital, Sheffield.
Anaesthesia
|April 1, 1991
Summary
Milrinone infusion effectively bridges patients with severe congestive heart failure from viral cardiomyopathy to heart transplantation. This treatment allowed weaning from mechanical support and improved organ perfusion.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Severe congestive heart failure (CHF) secondary to viral cardiomyopathy presents a critical challenge.
- Management often requires advanced cardiovascular support.
Observation:
- A patient with severe CHF due to viral cardiomyopathy was treated with milrinone infusion.
- Conventional support included an intra-aortic balloon pump and dobutamine.
Findings:
- Milrinone infusion facilitated clinical improvement in the patient.
- The patient was successfully weaned from the intra-aortic balloon pump and dobutamine.
- Organ perfusion demonstrated improvement during milrinone therapy.
Implications:
- Milrinone serves as a viable bridge therapy for heart transplantation in select CHF cases.
- This approach can potentially improve outcomes for patients awaiting cardiac allografts.